| 000 | 01441 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512100236.0 | ||
| 264 | 0 | _c19750423 | |
| 008 | 197504s 0 0 fre d | ||
| 022 | _a0029-4810 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoraine, C | |
| 245 | 0 | 0 |
_a[Ph1 and C group marker in a acute leukemia associated with noramidopyrine treatment (author's transl)]. _h[electronic resource] |
| 260 |
_bNouvelle revue francaise d'hematologie _c |
||
| 300 |
_a461-70 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAntipyrine _xadverse effects |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aChromosome Disorders |
| 650 | 0 | 4 | _aChromosomes, Human, 21-22 and Y |
| 650 | 0 | 4 | _aChromosomes, Human, 6-12 and X |
| 650 | 0 | 4 |
_aFever _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaryotyping |
| 650 | 0 | 4 |
_aLeukemia _xchemically induced |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xetiology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xetiology |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylamines _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xetiology |
| 700 | 1 | _aBrémond, J L | |
| 700 | 1 | _aDespert, F | |
| 700 | 1 | _aLeroy, J | |
| 700 | 1 | _aLeroux, M E | |
| 700 | 1 | _aMaillet, M | |
| 773 | 0 |
_tNouvelle revue francaise d'hematologie _gvol. 14 _gno. 4 _gp. 461-70 |
|
| 999 |
_c4285634 _d4285634 |
||